Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Toshihide Nishimura"'
Autor:
József Tímár, Sarolta Kárpáti, Charlotte Welinder, Viktória Doma, György Marko-Varga, Lotta Lundgren, Elisabet Wieslander, Ho Jeong Kwon, Krzysztof Pawłowski, Melinda Rezeli, Henrik Lindberg, Zsolt Horvath, Toshihide Nishimura, Indira Pla, Göran Jönsson, A. Marcell Szász, Magdalena Kuras, Jimmy Rodriguez Murillo, Yonghyo Kim, Jeovanis Gil, Roger Appelqvist, Johan Malm, Håkan Olsson, Lázaro Betancourt, Garry L. Corthals, Beatrice S. Knudsen, Yutaka Sugihara, Elisabeth Burestedt, Ethan Berge, Christian Ingvar, Peter Horvatovich, István Németh, Jonatan Eriksson, Boram Lee, Tasso Miliotis, Henriette Oskolas, Aniel Sanchez, Bo Baldetorp
Publikováno v:
Cell Biology and Toxicology
Cell biology and toxicology, 35(4), 293-332. SPRINGER
Cell biology and toxicology, 35(4), 293-332. SPRINGER
Melanoma of the skin is the sixth most common type of cancer in Europe and accounts for 3.4% of all diagnosed cancers. More alarming is the degree of recurrence that occurs with approximately 20% of patients lethally relapsing following treatment. Ma
Autor:
Masayuki Takagi, Kien Thiam Tan, Saeko Naruki, Shu-Jen Chen, Harubumi Kato, Hisashi Saji, Kiyonaga Fujii, Hirotaka Koizumi, Toshihide Nishimura, Haruhiko Nakamura, De-Wei Zhuo, Yasufumi Kato, Naoki Furuya
Publikováno v:
Scientific Reports
Scientific Reports, Vol 10, Iss 1, Pp 1-13 (2020)
Scientific Reports, Vol 10, Iss 1, Pp 1-13 (2020)
The tumourigenesis of early lung adenocarcinomas, including adenocarcinoma in situ (AIS), minimally invasive adenocarcinoma (MIA), and lepidic predominant invasive adenocarcinoma (LPA), remains unclear. This study aimed to capture disease-related mol
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Frontiers in Oncology
Frontiers in Oncology
Epidermal growth factor receptor EGFR major driver mutations may affect downstream molecular networks and pathways, which would influence treatment outcomes of non-small cell lung cancer (NSCLC). This study aimed to unveil profiles of mutant proteins
Autor:
Ákos Végvári, György Marko-Varga, Hisashi Saji, Haruhiko Nakamura, Toshihide Nishimura, Naoki Furuya
Publikováno v:
Expert review of proteomics. 16(9)
Introduction: Lung cancer is the leading cause of cancer death worldwide. Proteogenomics, a way to integrate genomics, transcriptomics, and proteomics, have emerged as a way to understand molecular causes in cancer tumorigenesis. This understanding w
Autor:
Yuka Miyata, Masahiro Hoshikawa, Tomoyuki Miyazawa, Hisashi Saji, Hiroki Sakai, Kouhei Tsumoto, Saeko Naruki, Hiroko Hata, Haruhiko Nakamura, Masayuki Takagi, Hirotaka Koizumu, Ikuya Takahashi, Vipul Gupta, Kiyonaga Fujii, Toshihide Nishimura
Publikováno v:
PLoS ONE
PLoS ONE, Vol 14, Iss 6, p e0217105 (2019)
PLoS ONE, Vol 14, Iss 6, p e0217105 (2019)
Small-cell lung carcinoma (SCLC) and large-cell neuroendocrine lung carcinoma (LCNEC) are high-grade lung neuroendocrine tumors (NET). However, comparative protein expression within SCLC and LCNEC remains unclear. Here, protein expression profiles we
Autor:
Noboru Nakayama, Yasuhiko Bando, Tetsuya Fukuda, Takeshi Kawamura, György Marko-Varga, Toshihide Nishimura, Haruhiko Nakamura
Publikováno v:
Drug Metabolism and Pharmacokinetics. 31:3-11
A strong demand in drug discovery and development today is to overcome "Big Gaps" encountered by differences in species and races, to accelerate effective developments in cost and time, and to meet medical needs. Moreover, drugs of various types have
Autor:
Toshihide Nishimura, Noboru Nakayama
Publikováno v:
Journal of the Mass Spectrometry Society of Japan. 64:65-69
Autor:
Kiyonaga Fujii, Hisashi Saji, Toshihide Nishimura, Hirotaka Koizumi, Yuka Miyata, Ikuya Takahashi, Haruhiko Nakamura, Masayuki Takagi, Masahiro Hoshikawa
Publikováno v:
Proteomics. Clinical applications. 12(6)
Purpose The molecular underpinnings that may prognosticate survival and increase our understanding of tumor development and progression are still poorly understood. This study aimed to define the molecular signatures for malignancy in small cell lung
Autor:
Akane Yamamichi, Akira Kato, Tomohide Nishikawa, Toshihide Nishimura, Yasuhiko Bando, Fumiharu Ohka, Toshihiko Wakabayashi, Tetsuya Fukuda, Ayako Motomura, Masahito Hara, Yusuke Nishimura, Kazuya Motomura, Hiroko Koyama, Atsushi Natsume, Mikiko Shimizu
Publikováno v:
Apoptosis : an international journal on programmed cell death. 22(11)
In previous clinical trials, we showed that remote ischemic preconditioning (rIPC) reduced myocardial damage in children undergoing treatment for congenital heart defects and postoperative renal failure in patients undergoing abdominal aortic aneurys
Autor:
Tetsuya Fukuda, Yasuhiko Bando, Kouhei Tsumoto, Toshihide Nishimura, Takeshi Kawamura, Noboru Nakayama, Satoru Nagatoishi, Naoko Obi, John Ervin
Publikováno v:
Rapid communications in mass spectrometry : RCM. 32(8)
Rationale Drug discovery studies invariably require qualitative and quantitative analyses of target compounds at every stage of drug discovery. We have developed a system combining molecular interaction analysis and mass spectrometry (LC-MS) using th